Mixed-function oxidase (MFO) induction in the mouse liver results in a rapid and sustained centrilobular hypertrophy associated with a hyperplastic response. In many studies, the long-term sequela of prolonged exposure is an increased incidence of lesions considered to be adenomas. Studies have shown in aged control mice that the burden of adenomas usually consists of lesions with basophilic cytoplasic staining and a uniform population of hepatocyte nuclei. With long-term feeding of MFO inducers, there is an additional burden of lesions diagnosed as adenomas having a different histological appearance with increased eosinophilic cytoplasm and pleomorphic nuclei. The incidence of hepatocarcinomas usually is not modified by the increased incidence of eosinophilic adenomas. Studies into the behavior of the eosinophilic lesions show that the hepatocytes approximate in their behavior to normal and not neoplastic cells. It is suggested that these lesions should not be considered a carcinogenic response to the chemical.
Andervont HB and Dunn TB (1952). Transplantation of spontaneous and induced hepatomas in inbred mice. J. Natl. Cancer Inst . 13: 455-503.
2.
Andervont HB , Grady HG, and Edwards SE (1942). Induction of hepatic lesions, hepatomas, pulmonary tumors and haemangioendotheliomas in mice with o-aminoazotoluene. J. Natl. Cancer Inst. 3: 131-153.
3.
Becker FF (1982). Morphological classification of mouse liver tumors based on biological characteristics. Cancer Res. 42: 3918-3923.
4.
Burback KM, Poland A., and Bradfield CA (1992). Cloning of the Ah-receptor c DNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci USA89: 8185-8189.
5.
Butler WH (1971). Pathology of liver cancer in experimental animals . In: Liver Cancer. Scientific Publication No. 1. I.A.R.C., Lyon, pp. 30-41.
6.
Butler WH (1979). Pesticide related lesions in the liver and their interpretation. In: Environmental Carcinogenesis. P Emmelot and E Kriek (eds). Elsevier, Amsterdam , pp. 193-201.
7.
Butler WH and Hempsall V. (1978). Histochemical observations on nodules induced in the mouse liver by phenobarbitone. J. Pathol. 125: 155-161.
8.
Chen B., Liu L., Castonguay A., Maronpot RR, Anderson MW, and You M. (1993). Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis14: 1603-1608.
9.
Collins MA, Lake BG, Evans JG, Gangolli SD, and Conning DM (1984). Sustained induction of hepatic xenobiotic metabolizing enzyme activities by phenobarbitone in C3H/He mice. Relevance to nodules formation . Toxicology33: 129-144.
10.
Cunninghame ME, Evans JG, and Butler WH (1991). An ultrastructural study of spontaneous and phenobarbitone-induced nodules in the mouse liver. Int. J. Exp. Pathol. 72: 695-703.
11.
Edwards JE and Dalton AJ (1942). Induction of cirrhosis of the liver and of hepatomas in mice with carbon tetrachloride. J. Natl. Cancer Inst. 3 : 19-41.
12.
Evans JG, Collins MA, Lake BG, and Butler WH (1992). The histology and development of hepatic nodules and carcinomas in C3H/He and C57BL/6 mice following chronic phenobarbitone administration. Toxicol. Pathol. 20: 585-594.
13.
Evans JG, Collins MA, Savage SA, Lake BS, and Butler WH (1986). The histology and development of hepatic nodules in C3H/He mice following chronic administration of phenobarbitone. Carcinogenesis7: 627-651.
14.
Fitzhugh OG and Nelson AA (1947). The chronic oral toxicity of DDT (2,2-bis(p-chlorophenyl-1,1,1-trichloroethane) . J. Pharmacol. Exp. Ther.89: 18-30.
15.
Fox TR, Schumann AM, Watanable PG, Yono BL, Maker VM, and McCormick JJ (1990). Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 × C3H/He mouse liver tumors and tumors induced with genotoxic and non-genotoxic hepatocarcinogens. Cancer Res. 50: 4014-4018.
16.
Gangolli SD , Lake BG, and Evans JG (1987). The histology and biochemistry of phenobarbitone-induced liver nodules in C3H mice. Arch. Toxicol. Suppl. 10: 95-107.
17.
Gellatly JBM (1975). The natural history of hepatic parenchymal nodule formation in a colony of C57/BL mice with reference to the effect of diet . In: Mouse Hepatic Neoplasia, WH Butler and PM Newberne (eds). Elsevier, Amsterdam , pp. 77-109.
18.
Grasso P. and Hardy J. (1975). Strain differences in natural incidence and response to carcinogens. In: Mouse Hepatic Neoplasia, WH Butler and PM Newberne (eds). Elsevier, Amsterdam , pp. 111-142.
19.
Hamm TE (1984). Occurrence of mouse liver neoplasms in the National Cancer Institute bioassays. In: Mouse Liver Neoplasia, Current Perspectives, JA Popp (ed). Hemisphere Publishing, Washington, D.C. , pp. 27-38.
20.
Hoffman EC, Reyes H., Chu F.-F., Sander F., Conley LH, Brooks BA, and Hankinson O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science252: 954-958.
21.
Ito N., Hananouchi H., Sugihara S., Shirai T., Tsuda H., Fukushima S., and Nagasaki H. (1976). Reversibility and irreversibility of liver tumors in mice induced by the α-isomer of 1,2,3,4,5,6-hexachlorocyclohexane. Cancer Res.36: 2227-2234.
22.
Jones G. and Butler WH (1975). Morphology of spontaneous and induced neoplasia . In: Mouse Hepatic Neoplasia, WH Butler and PM Newberne (ed). Elsevier, Amsterdam, pp. 21-25.
23.
Kyriazis AP , Koka M., and Vesselinovitch SD (1974). Metastatic characteristics of mouse liver tumors induced by diethylnitrosamine . Cancer Res. 34: 2881-2886.
24.
Lake BG, Collins MA, Evans JG, and Gangolli SD (1986). Effect of prolonged phenobarbital (PB) administration on hepatic xenobiotic metabolism and liver nodule formation in C3H/He and C57B2/6 mice. Toxicologist6: 230.
25.
Lake BG, Collins MA, Evans JG, and Gangolli SD (1986). Xenobiotic metabolising enzyme activities in spontaneous and phenobarbital (PB)-induced liver. Toxicologist6: 230.
26.
Malarkey DE , Devereux TR, Dime GE, and Maronpot RR (1995). Hepatocarcinogenicity of Chlordane in B6C3F1 and B6D2F1 male mice. Evidence for regression to B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation. Carcinogenesis16: 2617-2625.
27.
Maronpot RR , Fox T., Malarkey DE, and Goldsworthy TL (1995). Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology101: 125-156.
28.
Massey ED and Butler WH (1979). Zonal changes in the rat liver after chronic administration of phenobarbitone. An ultrastructural, morphometric and biochemical correlation . Chemico-Biol. Interact. 24: 329-344.
29.
McClain RM (1990). Mouse liver tumors and microsomal enzyme inducing drugs: Experimental and clinical perspective with phenobarbital. In: Mouse Liver Carcinogenesis: Mechanism of Species Comparisons, DE Stevenson et al (eds). Prog. Clin. Biol. Res. 331: 345-366.
30.
National Cancer Institute ( 1977). Bioassay of Chlordane for Possible Carcinogenicity. Publication No. 77-808, DHEW (NIH), Washington, D.C.
31.
National Cancer Institute (1977). Bioassay of Heptachlor for Possible Carcinogenicity. Publication No. 77-809, DHEW (NIH), Washington, D.C.
32.
National Cancer Institute (1978). Bioassay of DDT, TDE and p,p'-DDE for Possible Carcinogenicity. Technical Report No. 131 PB 286 367, DHEW (NIH), Washington, D.C.
33.
National Cancer Institute (1978). Bioassay of Dicofol for Possible Carcinogenicity. NCI Report No. 90, Publication No. 78-1340, DHEW (NIH), Washington, D.C.
34.
Pedrick MS, Rumsby PC, Wright V., Phillimore HE, Butler WH, and Evans JG (1994). Growth characteristics and Ha-ras mutations of all cultures isolated from chemically induced mouse liver tumors. Carcinogenesis15: 1847-1852.
35.
Pesticide Information Review and Evaluation Committee (1977). An Evaluation of the Carcinogenicity of Chlordane and Heptachlor. National Academy of Sciences , Washington, D.C.
36.
Reuber MD (1978). Carcinomas and other lesions of the liver in mice ingesting organochlorine pesticides. Clin. Toxicol. 13: 231-256.
37.
Ruebner BH, Gershwin ME, French SW, Meierheury E., Dunn D., and Hsieh LS (1984). Mouse hepatic neoplasia: Differences among strains and carcinogens. In: Mouse Liver Neoplasia, Current Perspectives , JA Popp (ed). Hemisphere Publishing, Washington, D.C. pp. 115-143.
38.
Rumsby PC, Barrass NC, Phillimore HE, and Evans JG (1991) Analysis of the Ha-ras oncogene in C3H/He mouse liver tumor derived spontaneously or induced with diethylnitrosamine or phen obarbitone. Carcinogenesis12: 2331-2336.
39.
Rumsby PC, Evans JG, Phillimore HE, Carthew P., and Smith A.( (1992). Search for Ha-ras codon 61 mutations in liver tumor caused by hexachlorobenzene and arochlor 1254 in C57BL/10ScS mice with iron overload. Carcinogenesis13: 1917-1920.
40.
Schulte-Herman R., Timmermann-Trosiener I., and Schappler (1983). Promotion of spontaneous pre-neoplastic cells in rat live as a possible explanation of tumor production by non mutagenic compound. Cancer Res. 43: 839-844.
41.
Society of Toxicologic Pathologists (1995). Guides for Toxicologic Pathology: Standardized System of Nomenclature and Diagnostic Criteria. Proliferative Lesions of the Mouse Liver (draft). Armed Forces Institute of Pathology , Washington, D.C.
42.
Stewart HL (1975). Comparative aspects of certain cancers. In: Cancer, Vol. 4, FF Becker (ed). Plenum Press, New York, pp. 303-374.
43.
Takahashi O. , Oishi S., Fujitani T., Tanaka T., and Yoneyama M. (1994). Piperonyl butoxide induces hepatocellular carcinoma in male CD-1 mice. Arch. Tox. 68: 467-469.
44.
Takayama S. (1968). Induction of transplantable liver tumors in DBF1 mice after oral administration of N,N'-2,7-fluorenylenebisacetamide . J. Natl. Cancer Inst.40: 629-641.
45.
Takayama S. and Inui N. (1967). Induction of malignant tumors in mice fed N,N'-2,7-fluorenylenebisacetamide. Gann58: 193-198.
46.
Takayama S. and Oota K. (1965). Induction of malignant tumors in various strains of mice by oral administration of N-nitro dimethylamine and N-nitrosodiethylamine. Gann56: 189-199.
47.
Tomatis L., Turusov V., Day N., and Charles RT (1972). The effect of long term exposure of DDT on CF-1 mice. Int. J. Cancer10: 489-506.
48.
Vesselinovitch SD and Milhailovich N. (1985). Kinetics of induction and growth of basophilic foci and development of hepatocellular carcinoma by diethylnitrosamine in the infant mouse. In: Mouse Liver Neoplasia, Current Perspectives, JA Popp (ed). Hemisphere Publishing, Washington, D.C., pp. 61-83.
49.
Vesselinovitch SD, Milhailovich N., and Rao KUN (1978). Morphology and metastatic nature of induced hepatic nodules lesions in C57BL × C3HF1 mice. Cancer Res. 38: 2003-2010.
50.
Walker AIT , Thorpe E., and Stevenson DE (1972). The toxicology of dieldrin (HEOD) I long term oral toxicity studies in mice. Fd. Cosmet. Toxic. 11: 415-432.
51.
Ward JM (1984). Morphology of potential pre-neoplastic hepatocyte lesions and liver tumors in mice and comparison with other species. In: Mouse Hepatic Neoplasia, Current Perspectives, JA Popp (ed). Hemisphere Publishing , Washington, D.C., pp. 1-26.
52.
Ward JH, Rice JM, Creasic D., Lynch P., and Riggs C. (1983). Dissimilar patterns of promotion by di(2-ethylhexyl) phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosine in B6C3F1 mice. Carcinogenesis4: 1021-1029.
53.
Watson MA, Devereux TR, Anderson MW, and Maronpot RR (1995). H-ras oncogene mutation spectra in B6C3F, and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. Carcinogenesis16: 1705-1710.
54.
Willis R. (1967). Definition of tumors. In: Pathology of Tumors. Butterworth, London, pp. 1-8.
